MGI Tech, Eurofins Genomics associate to advance precision health with revolutionary DNBSEQ-T20×2 sequencer and affiliated technologies

MGI Tech, a leader in life science tools, has partnered with Eurofins Genomics Europe Genotyping A/S (Eurofins Genomics). Eurofins Genomics placed the first corporate order in Europe for MGI’s DNBSEQ-T20×2 (T20) ultra-high throughput sequencer, the ZTRON Appliance genomics data centre, and other advanced laboratory automation products. This signifies a significant step in precision health initiatives across Europe.

Powered by MGI’s DNBSEQä technology, the T20 revolutionizes genetic sequencing, cutting costs to under $100 per genome for 50,000 WGS annually. It addresses diverse high-throughput sequencing needs in scientific and clinical research, including WGS, WGBS, stLFR, single-cell sequencing, and more. Since its February 2023 launch, the T20 has gained traction among leading global research institutions and healthcare providers.

Founded in 1990, Eurofins Genomics is part of the Eurofins Scientific Group, a major life science company with labs in over 50 countries and 55,000+ employees. Eurofins Genomics plays a crucial role in speciality esoteric and molecular clinical diagnostic testing in Europe and the US.